Vanderbilt Vaccine (VV) CRS (#30352) — Nashville, Tennessee

Vanderbilt Vaccine (VV) CRS (#30352) is a clinical research site located in Nashville, Tennessee, United States 37232.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Vanderbilt Vaccine (VV) CRS (#30352) has participated in 1 clinical trials.

Therapeutic areas: HIV-1-infection.

Sponsors: National Institute of Allergy and Infectious Diseases (NIAID).

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Vanderbilt Vaccine (VV) CRS (#30352)?

Vanderbilt Vaccine (VV) CRS (#30352) has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Vanderbilt Vaccine (VV) CRS (#30352) conducted?

Vanderbilt Vaccine (VV) CRS (#30352) has 1 clinical trials on record. Their work covers HIV-1-infection.

Is Vanderbilt Vaccine (VV) CRS (#30352) accredited by Crixeo Health?

Vanderbilt Vaccine (VV) CRS (#30352) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Vanderbilt Vaccine (VV) CRS (#30352)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.